首页> 外文期刊>Nephron >Vitamin D, surface electromyography and physical function in uraemic patients
【24h】

Vitamin D, surface electromyography and physical function in uraemic patients

机译:尿毒症患者的维生素D,表面肌电图和身体机能

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Muscle function is impaired in uraemic patients and several causes have been proposed. Deficiency of 25-hydroxyvitamin D (25-OHD), which affects muscle function in non-uraemic patients, may very well also be associated with the myopathy found in these patients. The aim of this study was to investigate the association between 25-OHD and muscle function as well as physical function in chronic kidney disease (CKD) and peritoneal dialysis (PD) patients. Methods: In this cross-sectional study, 21 adult patients with CKD stage 3-5 and 21 patients treated with PD were included. Standard biochemistry parameters were measured including 25-OHD, 1,25-dihydroxycholecalciferol (1,25-OHD) and parathyroid hormone analysis. Muscle function was determined by 30-second surface electromyography (sEMG) recordings of a right thigh muscle (vastus lateralis) and a second left finger muscle (second dorsal interosseous) under voluntary contractions. Physical function was determined using a 30-second Chair Stand Test and the Short Form 36 quality of life questionnaire. Clinical characteristics were collected from the patient records. Results: Moderate vitamin 25-OHD deficiency (<40 nmol/l) was measured in 52% of patients with CKD and in 71% of the patients on PD. Severe deficiency (<15 nmol/l) was measured in 14% of patients on PD. There were no significant differences between the CKD and PD patients in terms of sEMG results. 25-OHD was not correlated to any results from the tests of sEMG or physical function. However, a higher sEMG frequency and signal root mean square (RMS) were positively associated with a higher Chair Stand Test score. Time to maximum sEMG frequency was negatively correlated to the Chair Stand Test score (p < 0.05), and positively correlated to the level of comorbidity (p < 0.05). sEMG signal peak-peak amplitude, frequency and RMS were positively correlated to the quality of life scales Physical Function, Role Physical, General Health, Vitality, Social Function, Mental Health, and Physical Component Scale (p < 0.001). Conclusions: 25-OHD deficiency was prevalent in uraemic patients in the present study. Muscle function as determined using sEMG and the Chair Stand Test was not associated with 25-OHD. The results may be biased by the limited variation in 25-OHD and masked by effects of several other variables in this very sick population.
机译:背景:尿毒症患者的肌肉功能受损,并提出了几种原因。影响非尿毒症患者肌肉功能的25-羟基维生素D(25-OHD)缺乏也可能与这些患者的肌病有关。这项研究的目的是调查慢性肾脏病(CKD)和腹膜透析(PD)患者中25-OHD与肌肉功能以及身体功能之间的关系。方法:本横断面研究包括21例CKD 3-5期的成年患者和21例接受PD治疗的患者。测量了标准生化参数,包括25-OHD,1,25-二羟基胆钙化固醇(1,25-OHD)和甲状旁腺激素分析。肌肉功能由30秒的表面肌电图(sEMG)记录,该记录是在自愿收缩下右大腿肌肉(外侧输精管)和第二左手指肌肉(第二背骨间)进行的。使用30秒的座椅站立测试和简短的36型生活质量问卷来确定身体机能。从患者记录中收集临床特征。结果:52%的CKD患者和71%的PD患者测得中度维生素25-OHD缺乏症(<40 nmol / l)。在14%的PD患者中检测到严重缺乏症(<15 nmol / l)。在sEMG结果方面,CKD和PD患者之间无显着差异。 25-OHD与sEMG或身体功能测试的任何结果均不相关。但是,较高的sEMG频率和信号均方根(RMS)与较高的座椅标准测试得分呈正相关。达到最大sEMG频率的时间与Chair Stand测试得分负相关(p <0.05),与合并症水平正相关(p <0.05)。 sEMG信号的峰-峰值幅度,频率和RMS与生活质量量表,身体机能,角色身体,总体健康,生命力,社会功能,心理健康和身体成分量表呈正相关(p <0.001)。结论:本研究中尿毒症患者中普遍存在25-OHD缺乏症。使用sEMG和“座椅站立测试”确定的肌肉功能与25-OHD不相关。结果可能会因25-OHD的有限变化而产生偏差,并可能被这个非常患病的人群中其他几个变量的影响所掩盖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号